期刊文献+

丹参多酚酸盐注射液对实验性结肠炎小鼠血清脂肪因子水平的影响 被引量:2

Effect of Salvianolic injection on the adipokines of mice with experimental colitis
下载PDF
导出
摘要 目的通过测试血清脂肪因子水平,了解丹参多酚酸盐是否对脂肪因子产生影响,进一步探讨丹参多酚酸盐治疗实验性结肠炎的可能机制。方法选用雄性BALB/C小鼠30只随机分为对照组、模型组、丹参多酚酸盐干预组,饮用5%DSS造模,14 d后检测相应指标。结果与模型组比较,干预组的肠道炎症明显减轻(P<0.01)。模型组小鼠血清瘦素、趋化素均较对照组升高(P<0.05),但脂联素降低(P<0.05);干预组仅血清瘦素较模型组低(P<0.05),脂联素和趋化素与模型组相比,差异无统计学意义(P>0.05)。结论丹参多酚酸盐对小鼠实验性结肠炎具有一定的治疗作用,其机制之一可能是调节脂肪因子。 Objective To observe the treatment effect of Salvianolic injection on the adipokines of mice with experi-mental colitis and investigate the possible mechanism of it .Methods Thirty BALB/C mice were randomly divided into control group, modle group and interventional group .Colitis was induced by 5%DSS oral administration for 7 d.14 d later, indices were determined .Results Treatment of mice with Salvianolic injection could reduce colon inflammation induced by DSS ( P〈0 .01 ) .Serum chemerin , leptin were higher in the model group than those in the control group ( P〈0.05), but adiponectin decreased (P〈0.05).Leptin decreased in the interventional group (P〈0.05), while the changes of chemerin and adiponectin had no statistically significance ( P〉0 .05 ) .Conclusion Salvianolic injection have some theroputic effect on colitis in mice ,and the mechanism maybe due to its regulation effcet on adipokines .
出处 《胃肠病学和肝病学杂志》 CAS 2015年第4期418-420,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 炎症性肠病 丹参多酚酸注射液 脂肪因子 Inflammatory bowel disease Salvianolic injection Adipokine
  • 相关文献

参考文献14

  • 1朱榕峰,杨颖,陈名道.Chemerin:一个新的脂肪细胞因子[J].国际内分泌代谢杂志,2009,29(2):107-109. 被引量:3
  • 2王兴洲,陈军建.脂肪因子chemerin研究进展[J].医学综述,2009,15(7):994-997. 被引量:7
  • 3顾頠,庞智,皇甫照,华江,周春立,沈必武.活动期炎症性肠病患者中血清chemerin水平及其临床意义[J].胃肠病学,2010,15(7):405-407. 被引量:4
  • 4Weigert J, Obermeier E, Neumeier M, et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn' s disease [J]. Inflamm Bowel Dis, 2010, 16 (4) : 630-637.
  • 5Batra A, Siegmund B. Leptin and gastrointestinal inflammation. Fan- tuzzi G, Mazzone T, editor. Nutrition and health: adipose tissue and adipokines in health and disease [ M]. Totowa: Humana Press, New Jersey, 2007 : 101-110.
  • 6Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resistin, and ghrelin-implications for inflammatory bowel disease [ J ]. Mol Nutr Food Res, 2008, 52(8): 855-866.
  • 7Biesiada G, Czepiel J, Ptak-Belowska A, et al. Expression and release of leptin and proinflammatory eytokines in patients with ulcerative coli- tis and infectious diarrhea [ J]. J Physiol Pharmacol, 2012, 63 (5) : 471-481.
  • 8Singh UP, Singh NP, Guan H, et al. Leptin antagonist ameliorates chronic colitis in IL-10-/- mice [J]. Immunobiology, 2013, 218 (12) : 1439-1451.
  • 9Singh UP, Singh NP, Guan H, et al. The emerging role of leptin antago- nist as potential therapeutic option for inflammatory bowel disease [ J ]. lnt Rev Immunol, 2014, 33(1): 23-33.
  • 10Yamamoto K, Kiyohara T, Murayama Y, et al. Production of adi- ponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn'sdisease [J]. Gut, 2005, 54(6): 789-796.

二级参考文献109

  • 1阮佼.CD40/CD40L共刺激途径与炎症性肠病研究进展[J].现代医药卫生,2005,21(24):3400-3401. 被引量:2
  • 2陈隆典,杨英.炎症性肠病疾病活动程度与血小板参数的相关性分析[J].中华消化杂志,2006,26(11):771-771. 被引量:21
  • 3刘隽,李晓红.CD28:CTLA4/B7及CD40/CD40L在炎症性肠病发病机制中的作用[J].国际消化病杂志,2006,26(6):377-379. 被引量:1
  • 4Nagpal S, Patel S, Jacobe H, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol, 1997,109:91-95.
  • 5Parmentier M. Characterization of new chemoattractant agents in leukocytes. Bull Mere Acad R Med Belg,2004 ,159 :515-520.
  • 6Wittamer V, Franssen JD,Vulcano M, et al. Specific recruitment of antigen-presenting ceils by chemerin ,a novel processed ligand from human inflammatory fluids. J Exp Med ,2003,198:977-985.
  • 7Zabel BA,Allen SJ,Kulig P,et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem,2005,280 : 34661-34666.
  • 8Wittamer V, Bondue B, Guillabert A, et al. Neutrophil-mediated maturation of chemerin : a link between innate and adaptive immunity. J Immunol,2005 ,175 :487493.
  • 9Du XY,Zabel BA, Myles T, et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B ( TAF- Ia) and platelets. J Biol Chem,2009 ,284 :751-758.
  • 10Wittamer V, Gregoire F, Robberecht P, et al. The C-terminal non-apeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem,2004 ,279 :9956-9962.

共引文献30

同被引文献17

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部